Literature DB >> 10963338

Ineffective control of murine cytomegalovirus by IE1-specific cytotoxic T lymphocytes during protracted infection in the lung.

Q J Chen1, H Yoshida, H Takimoto, T Ninomiya, M Ohtsu, G Kimura, K Nomoto.   

Abstract

Interstitial pneumonia caused by cytomegalovirus (CMV) is a fatal disease in immunocompromised patients. In order to examine the defense mechanism against the virus in the lung, we employed an intratracheal infection model in susceptible mice. In mice infected intratracheally with murine CMV, a protracted infection was observed where infectious virus was detected up to 21 days of infection. During this prolonged infection, massive accumulation in the lung of CD8+ T cells with activated phenotypes occurred and these CD8+ T cells showed direct ex vivo cytolytic activity against target cells pulsed with the nonamer peptide derived from IE1 protein of the virus, which has been shown to be the dominant epitope recognized by most of virus-specific CTL. Moreover, adoptive transfer of in vitro induced IE1 peptide-specific CTL line showed no anti-virus effect in the lung, although they were effective in the spleen. Hence, there is reason to assume the IE1-specific CTL induced in vivo or in vitro plays limited roles during the prolonged infection in the lung.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963338     DOI: 10.1007/s007050070091

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  2 in total

1.  Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation.

Authors:  O Kanemi; X Zhang; Y Sakamoto; M Ebina; R Nagatomi
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.

Authors:  M Bani-Ahmad; I S El-Amouri; C M Ko; F Lin; Y Tang-Feldman; O R Oakley
Journal:  Clin Exp Immunol       Date:  2010-12-16       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.